• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Changes in the seroepidemiology of hepatitis B infection in Catalonia 1989-1996.

作者信息

Domínguez A, Bruguera M, Vidal J, Plans P, Salleras L

机构信息

Directorate of Public Health, Department of Health and Social Security, Barcelona, Spain.

出版信息

Vaccine. 2000 May 8;18(22):2345-50. doi: 10.1016/s0264-410x(00)00028-1.

DOI:10.1016/s0264-410x(00)00028-1
PMID:10738090
Abstract

The objective of this study was to investigate the prevalence of hepatitis B markers in a representative sample of 2142 subjects in Catalonia, Spain, and to compare it with previous studies. Multiple logistical regression analysis was carried out to determine variables associated with the markers studied. The prevalence of anti-HBc and HBsAg was 9.1% and 1.2%, respectively. Male gender, urban habitat, birth place outside Catalonia and lower social class were associated with the presence of anti-HBc. Carrier status was only associated with male gender. Between 1989 and 1996 there was a decrease of 46% in the prevalence of serum HBV markers mainly in the 25-44 (P<0.0001) and 35-64 year (P=0.0002) age groups, in those born in Catalonia (P=0.003) and in those in the higher social classes (P<0.0001). These decreases can be explained by the improved socioeconomic conditions and, partially, by the routine pre-adolescent and risk group programmes of immunization.

摘要

相似文献

1
Changes in the seroepidemiology of hepatitis B infection in Catalonia 1989-1996.
Vaccine. 2000 May 8;18(22):2345-50. doi: 10.1016/s0264-410x(00)00028-1.
2
Declining prevalence of hepatitis B virus infection in Catalonia (Spain) 12 years after the introduction of universal vaccination.西班牙加泰罗尼亚地区实施全民乙肝疫苗接种12年后乙肝病毒感染率下降情况
Vaccine. 2007 Dec 17;25(52):8726-31. doi: 10.1016/j.vaccine.2007.10.027. Epub 2007 Nov 5.
3
Seroepidemiology of hepatitis B virus infection in pregnant women in Catalonia (Spain).西班牙加泰罗尼亚地区孕妇乙肝病毒感染的血清流行病学研究
J Clin Virol. 2009 Apr;44(4):329-32. doi: 10.1016/j.jcv.2009.01.002. Epub 2009 Feb 20.
4
Prevalence of hepatitis B markers in the population of Catalonia (Spain). Rationale for universal vaccination of adolescents.西班牙加泰罗尼亚地区人群乙肝标志物的流行情况。青少年普遍接种疫苗的理论依据。
Eur J Epidemiol. 1992 Sep;8(5):640-4. doi: 10.1007/BF00145377.
5
Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.伊朗哈马丹省乙型肝炎、丁型肝炎和人类免疫缺陷病毒感染的血清流行病学:一项基于人群的研究。
J Trop Med Hyg. 1993 Oct;96(5):277-87.
6
Impact of hepatitis B vaccination among children in Guangdong Province, China.中国广东省儿童乙型肝炎疫苗接种的影响。
Int J Infect Dis. 2012 Sep;16(9):e692-6. doi: 10.1016/j.ijid.2012.05.1027. Epub 2012 Jul 13.
7
Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.西班牙接受肝移植评估的肝硬化患者中乙型和甲型肝炎病毒标志物的流行情况及疫苗接种指征
Transplant Proc. 2012 Jul-Aug;44(6):1502-4. doi: 10.1016/j.transproceed.2012.05.020.
8
Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination.在完全接种疫苗后,18 岁以上个体中出现 s 基因发生突变的乙肝病毒 DNA 血清阳性率增加。
Gastroenterology. 2012 Aug;143(2):400-7. doi: 10.1053/j.gastro.2012.05.002. Epub 2012 May 10.
9
[Sero-epidemiological analysis on hepatitis B among children aged 1-14 years old born to HBsAg positive mother in China, 2014].[2014年中国HBsAg阳性母亲所生1-14岁儿童乙肝血清流行病学分析]
Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Apr 10;38(4):457-461. doi: 10.3760/cma.j.issn.0254-6450.2017.04.009.
10
The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.南非乙肝疫苗普及接种的头五年:5岁以下儿童乙肝表面抗原携带率消除的证据
Vaccine. 2001 Jul 16;19(28-29):3919-26. doi: 10.1016/s0264-410x(01)00120-7.

引用本文的文献

1
Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.在欧洲,乙型肝炎和丙型肝炎病毒感染:筛查的流行率和成本效益的系统评价。
BMC Infect Dis. 2013 Apr 18;13:181. doi: 10.1186/1471-2334-13-181.
2
Long term protection after hepatitis B vaccination.乙肝疫苗接种后的长期保护作用。
Bosn J Basic Med Sci. 2005 Aug;5(3):50-3.